Objective To identify the optimal dose and type of physical activity to improve functional capacity and reduce adverse events in acutely hospitalised older adults. Design Systematic review and ...

A follow-up study suggests that aspirin therapy does not reduce cancer risk in older adults, but may instead increase cancer-related mortality risk.

In this retrospective study, researchers explored whether reducing osimertinib dose in EGFR-mutated metastatic NSCLC patients who experienced adverse events would worsen survival.

Adverse effects associated with glucocorticoid use among patients with rheumatoid arthritis may not be as burdensome as previously indicated. Glucocorticoids are one of the most common methods for ...

Higher peak doses of corticosteroids to counter the immune-related adverse effects (irAEs) of immune checkpoint inhibitor (ICI) combination therapy had a significant association with worse survival ...

A higher dose of anti-T-lymphocyte globulin (ATLG) significantly outperformed a lower dose in preventing graft-vs-host disease (GVHD) in patients receiving matched –sibling donor (MSD) peripheral ...

Serplulimab achieves pharmacodynamic saturation, supporting its current clinical use without the need for higher doses. The ASTRUM-005 trial established serplulimab as the PD-1 inhibitor with the ...

After pneumococcal disease and colonization have been controlled through vaccination campaigns, a reduced pneumococcal conjugate vaccine (PCV) schedule may be sufficient to sustain that control at ...

By Dr. Sanchari Sinha Dutta, Ph.D. A large Danish trial analysis suggests high-dose flu vaccines may offer extra protection ...